|
US5175320A
(en)
|
1989-04-17 |
1992-12-29 |
Giuliani S.P.A. |
Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
|
|
CA2253593C
(en)
|
1996-05-23 |
2008-07-08 |
Novartis Ag |
Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)
|
|
DK1392714T3
(da)
|
2001-03-12 |
2006-01-09 |
Intercept Pharmaceuticals Inc |
Steroider som agonister for FXR
|
|
WO2003039480A2
(en)
|
2001-11-08 |
2003-05-15 |
The University Of Chicago |
Method of treating disorder related to high cholesterol concentration
|
|
EP1568706A1
(en)
|
2004-02-26 |
2005-08-31 |
Intercept Pharmaceuticals, Inc. |
Novel steroid agonist for FXR
|
|
WO2005089316A2
(en)
|
2004-03-12 |
2005-09-29 |
Intercept Pharmaceuticals, Inc. |
Treatment of fibrosis using fxr ligands
|
|
US7276585B2
(en)
|
2004-03-24 |
2007-10-02 |
Xencor, Inc. |
Immunoglobulin variants outside the Fc region
|
|
ITMI20050912A1
(it)
|
2005-05-19 |
2006-11-20 |
Erregierre Spa |
Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
|
|
CN101395170A
(zh)
|
2006-02-14 |
2009-03-25 |
英特塞普特药品公司 |
用于预防或治疗fxr介导的疾病或状态的作为fxr配体的胆汁酸衍生物
|
|
DK2040713T3
(da)
|
2006-06-27 |
2014-09-29 |
Intercept Pharmaceuticals Inc |
Galdesyrederivater som fxr-ligander til forebyggelsen eller behandlingen af fxr-medierede sygdomme eller tilstande
|
|
CA2928178C
(en)
|
2007-01-19 |
2019-09-10 |
Intercept Pharmaceuticals, Inc. |
Tgr5 modulators and methods of use thereof
|
|
US8796249B2
(en)
|
2008-07-30 |
2014-08-05 |
Intercept Pharmaceuticals, Inc. |
TGR5 modulators and methods of use thereof
|
|
HUE039171T2
(hu)
|
2008-11-19 |
2018-12-28 |
Intercept Pharmaceuticals Inc |
TGR5 modulátorok és azok alkalmazási eljárása
|
|
AU2009316484B2
(en)
|
2008-11-19 |
2015-04-16 |
Intercept Pharmaceuticals, Inc. |
TGR5 modulators and methods of use thereof
|
|
ES2822375T3
(es)
|
2012-06-19 |
2021-04-30 |
Intercept Pharmaceuticals Inc |
Preparación de la forma no cristalina del ácido obeticólico
|
|
NZ707389A
(en)
|
2012-10-26 |
2018-08-31 |
Intercept Pharmaceuticals Inc |
Process for preparing bile acid derivatives
|
|
US20140206657A1
(en)
|
2013-01-18 |
2014-07-24 |
City Of Hope |
Bile acid analog tgr5 agonists
|
|
CN112057457A
(zh)
|
2013-03-13 |
2020-12-11 |
萨奇治疗股份有限公司 |
神经活性类固醇、组合物、及其用途
|
|
CN105377870B
(zh)
|
2013-05-14 |
2018-04-03 |
英特塞普特医药品公司 |
作为法尼醇x受体调节剂的胆汁酸的11‑羟基衍生物及其氨基酸共轭物
|
|
WO2015085474A1
(zh)
|
2013-12-10 |
2015-06-18 |
华为终端有限公司 |
一种注册方法和相关节点以及注册系统
|
|
BR112017009657A2
(pt)
|
2014-11-06 |
2018-01-23 |
Enanta Pharmaceuticals, Inc |
análogos de ácidos biliares como agonistas de fxr/tgr5 e métodos de uso dos mesmos
|
|
ES2748692T3
(es)
|
2014-11-19 |
2020-03-17 |
Nzp Uk Ltd |
Esteroides 6.alfa.-alquil-3,7-diona como intermedios para la producción de moduladores FXR de esteroides
|
|
KR102526632B1
(ko)
|
2014-11-19 |
2023-04-27 |
엔제트피 유케이 리미티드 |
스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드
|
|
JP6698085B2
(ja)
|
2014-11-19 |
2020-05-27 |
エヌゼットピー ユーケー リミテッド |
ステロイドＦＸＲモジュレーター製造のための中間体としての６α−アルキル−６，７−ジオン−ステロイド
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
RU2017121457A
(ru)
|
2014-11-26 |
2018-12-26 |
Энанта Фармасьютикалс, Инк. |
Аналоги желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения
|
|
WO2016086115A1
(en)
|
2014-11-26 |
2016-06-02 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
|
|
WO2016086134A1
(en)
|
2014-11-26 |
2016-06-02 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
CN105348365A
(zh)
|
2014-12-03 |
2016-02-24 |
四川百利药业有限责任公司 |
一种胆酸衍生物及其制备方法、药物组合物和用途
|
|
ES2905872T3
(es)
|
2015-02-06 |
2022-04-12 |
Intercept Pharmaceuticals Inc |
Composiciones farmacéuticas para terapia combinada
|
|
AU2016219266A1
(en)
|
2015-02-11 |
2017-08-10 |
Enanta Pharmaceuticals, Inc. |
Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
|
|
JP2018507880A
(ja)
|
2015-03-09 |
2018-03-22 |
インターセプト ファーマシューティカルズ， インコーポレイテッド |
骨密度を調節する方法
|
|
CN107531741A
(zh)
|
2015-03-10 |
2018-01-02 |
美莱斯股份有限公司 |
氟化和烷基化胆酸
|
|
US20160279393A1
(en)
|
2015-03-25 |
2016-09-29 |
Covidien Lp |
Guidewire retrieval catheter
|
|
RU2712099C2
(ru)
|
2015-03-31 |
2020-01-24 |
Энанта Фармасьютикалс, Инк. |
Производные желчных кислот в качестве агонистов fxr/tgr5 и способы их применения
|
|
CN107613986A
(zh)
|
2015-04-07 |
2018-01-19 |
英特塞普特医药品公司 |
用于组合疗法的药物组合物
|
|
PE20180690A1
(es)
|
2015-04-27 |
2018-04-23 |
Intercept Pharmaceuticals Inc |
Composiciones de acido obeticolico y metodos de uso
|
|
WO2016173493A1
(en)
*
|
2015-04-28 |
2016-11-03 |
Shanghai De Novo Pharmatech Co. Ltd. |
Sulfonylaminocarbonyl derivative, pharmaceutical composition and uses thereof
|
|
WO2016173397A1
(zh)
|
2015-04-28 |
2016-11-03 |
上海翰森生物医药科技有限公司 |
胆酸衍生物及其制备方法和医药用途
|
|
TW201704251A
(zh)
|
2015-04-29 |
2017-02-01 |
正大天晴藥業集團股份有限公司 |
鵝去氧膽酸衍生物
|
|
CN106210599B
(zh)
|
2015-04-30 |
2021-02-12 |
中兴通讯股份有限公司 |
一种多画面调整方法、装置及多点控制单元
|
|
TW201700447A
(zh)
|
2015-06-19 |
2017-01-01 |
英特賽普醫藥品公司 |
Tgr5調控劑及其用法
|
|
BR112018001869A2
(pt)
|
2015-07-30 |
2018-09-18 |
Intercept Pharmaceuticals Inc |
método para preparação de ácidos biliares e derivados dos mesmos
|
|
EP3331896A4
(en)
|
2015-08-07 |
2019-08-14 |
Intercept Pharmaceuticals, Inc. |
PROCESS FOR THE PRODUCTION OF GALLENIC ACID AND DERIVATIVES THEREOF
|
|
CN106518946A
(zh)
|
2015-09-10 |
2017-03-22 |
上海迪诺医药科技有限公司 |
磺酰脲衍生物、其药物组合物及应用
|
|
AU2016326428A1
(en)
|
2015-09-21 |
2018-04-12 |
Intercept Pharmaceuticals, Inc. |
Methods of promoting hepatic regeneration
|
|
KR20180052756A
(ko)
|
2015-09-24 |
2018-05-18 |
인터셉트 파마슈티컬즈, 인크. |
담즙산 유도체 제조를 위한 방법 및 중간체
|
|
EP3359160B1
(en)
|
2015-10-07 |
2021-08-25 |
Intercept Pharmaceuticals, Inc. |
Farnesoid x receptor modulators
|
|
CN108348533A
(zh)
|
2015-11-06 |
2018-07-31 |
英特塞普特医药品公司 |
制备奥贝胆酸及其衍生物的方法
|
|
CA3009149A1
(en)
|
2015-12-22 |
2017-06-29 |
Intercept Pharmaceuticals, Inc. |
Polymorphic crystalline forms of obeticholic acid
|
|
CN105646634A
(zh)
|
2016-01-29 |
2016-06-08 |
中国药科大学 |
奥贝胆酸杂质的制备方法
|
|
US10323060B2
(en)
|
2016-02-23 |
2019-06-18 |
Enanta Pharmaceuticals, Inc. |
Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
|
|
WO2017147174A1
(en)
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Heteroaryl containing bile acid analogs as fxr/tgr5 agonists and methods of use thereof
|
|
US10364267B2
(en)
|
2016-02-23 |
2019-07-30 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
EA038632B1
(ru)
|
2016-03-11 |
2021-09-27 |
Интерсепт Фармасьютикалз, Инк. |
7,11-дигидрокси-6-этил-5-холан-24-овая кислота и фармацевтические композиции на ее основе для лечения или предупреждения заболевания или состояния, опосредованных фарнезоидным х-рецептором (fxr)
|
|
GB201608777D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Compounds
|
|
GB201608776D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Methods and compounds
|
|
GB201608779D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Methods and compounds
|